HHS Moves to Boost Production of Vaccine-Manufacturing Supplies

Feb. 18, 2021, 7:46 PM UTC

The federal government is looking to finance the expansion of domestic production in supplies necessary to manufacture Covid-19 vaccines, according to the General Services Administration.

The Biomedical Advanced Research and Development Authority on Wednesday issued three requests for proposals to expand its supply of these pharmaceutical consumables, which are used during vaccine production. Any awarded contracts would be to “expand existing US based manufacturing capacity” for the supplies.

BARDA, part of the Department of Health and Human Services, helps develop countermeasures against emerging diseases. The agency regularly finances new technologies, drugs, and devices that can be used during a public ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.